E. J. Salaski

发表

Discovery of highly potent and selective type I B-Raf kinase inhibitors.

D. Berger, D. Powell, Nancy Torres, 2009, Bioorganic & medicinal chemistry letters.

Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.

R. Black, J. Skotnicki, J. Levin, 2003, Bioorganic & medicinal chemistry letters.

Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT/PKB: mechanistic involvement of AKT catalytic activation loop cysteines

R. Abraham, P. Cai, J. Levin, 2007, Molecular Cancer Therapeutics.

Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity.

D. Berger, M. Dutia, D. Powell, 2010, Journal of medicinal chemistry.

Dramatic effect of solvent hydrogen bond basicity on the regiochemistry of S(N)Ar reactions of electron-deficient polyfluoroarenes.

D. Berger, D. Powell, Xiaolun Wang, 2009, Organic letters.

Efficient total synthesis of (.+-.)-anatoxin a

J. M. Morin, E. J. Salaski, R. Danheiser, 1985 .

Pyranonaphthoquinone lactones: a new class of AKT selective kinase inhibitors alkylate a regulatory loop cysteine.

D. Powell, J. Levin, L. Toral-Barza, 2009, Journal of medicinal chemistry.

GMP Synthetase: Synthesis and Biological Evaluation of a Stable Analog of the Proposed AMP-XMP Reaction Intermediate

E. J. Salaski, H. Maag, 1999 .

Synthesis of 3,3‐Dimethyl‐4‐chromanones: Improved Procedures Without Ring Opening

T. Mansour, A. Yamashita, Emily B. Norton, 2006 .

Preparation of (−)-aristolochene from (+)-valencene: Absolute configuration of (+)-aristolochene from aspergillus terreus.

D. Cane, E. J. Salaski, P. Prabhakaran, 1990 .

Aristolochene biosynthesis and enzymatic cyclization of farnesyl pyrophosphate

D. Cane, H. Noguchi, E. J. Salaski, 1989 .

Structure-based design of isoindoline-1,3-diones and 2,3-dihydrophthalazine-1,4-diones as novel B-Raf inhibitors.

D. Berger, D. Powell, D. Wojciechowicz, 2011, Bioorganic & medicinal chemistry letters.

Protein farnesyltransferase inhibitors.

S. Ayral-Kaloustian, E. J. Salaski, 2002, Current medicinal chemistry.

Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.

R. Black, J. Skotnicki, J. Levin, 2003, Bioorganic & medicinal chemistry letters.